BPC-157 / TB-500 Blend | Research Grade

The BPC-157 / TB-500 Blend | Research Grade is a paired research bundle of BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4 fragment) — the most-cited two-peptide combination in connective-tissue and tendon-repair research literature. Research-grade specs Components: BPC-157 10mg TB-500 10mg Mechanism: Complementary — growth factor signaling cell migration Studied applications Connective tissue repair research Tendon and ligament healing studies Comparative single-vs-combined mechanism research Research replication of the most-cited stack in the literature Quality & trust ≥99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included USA same-day shipping (orders before 2pm CT M-F) Related research: BPC-157 alone · TB-500 alone · BPC-157 vs TB-500 comparison Research literature BPC-157 AND TB-500 has been the subject of 3 peer-reviewed publications indexed in PubMed. Selected recent literature for research reference: Mendias CL et al. (2026). Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. PMID: 41966639 Rahman OF et al. (2026). Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. J Am Acad Orthop Surg Glob Res Rev. PMID: 41490200 Mayfield CK et al. (2026). Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med. PMID: 41476424 References are provided for research reference only. Inclusion of literature does not constitute a recommendation, endorsement, or claim for any specific use of LiveWell Peptides products. Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body.